FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib

被引：0

作者：

Lixia Gao

Xuli Wang

Yaoliang Tang

Shuang Huang

Chien-An Andy Hu

Yong Teng

机构：

[1] Augusta University,Department of Oral Biology, Dental College of Georgia

[2] University of Utah,Department of Radiology and Imaging Sciences, School of Medicine

[3] University of Utah,Experimental Therapeutics Program, Huntsman Cancer Institute

[4] Augusta University,Vascular Biology Center, Department of Medicine, Medical College of Georgia

[5] University of Florida College of Medicine,Department of Anatomy and Cell Biology

[6] University of New Mexico School of Medicine,Department of Biochemistry and Molecular Biology

[7] Augusta University,Department of Biochemistry and Molecular Biology, Medical College of Georgia

来源：

Journal of Experimental & Clinical Cancer Research | / 36卷

关键词：

FGF19; FGFR4; Hepatocellular carcinoma; Drug resistance; Sorafenib; Synergistic effect;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?
Berasain, Carmen
GUT, 2013, 62 (12) : 1674 - 1675
[42] Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma
Shigesawa, Taku
Suda, Goki
Kimura, Megumi
Shimazaki, Tomoe
Maehara, Osamu
Yamada, Ren
Kitagataya, Takashi
Suzuki, Kazuharu
Nakamura, Akihisa
Ohara, Masatsugu
Umemura, Machiko
Kawagishi, Naoki
Nakai, Masato
Sho, Takuya
Natsuizaka, Mitsuteru
Morikawa, Kenichi
Ogawa, Koji
Sakamoto, Naoya
JGH OPEN, 2020, 4 (05): : 880 - 888
[43] FGF19 Contributes to Tumor Progression in Gastric Cancer by Promoting Migration and Invasion
Wang, Shuang
Zhao, Daqi
Tian, Ruihua
Shi, Hailong
Chen, Xiangming
Liu, Wenzhi
Wei, Lin
ONCOLOGY RESEARCH, 2016, 23 (04) : 197 - 203
[44] Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study
Kang, Hyo Jeong
Haq, Farhan
Sung, Chang Ohk
Choi, Jene
Hong, Seung-Mo
Eo, Soo-Heang
Jeong, Hui Jeong
Shin, Jinho
Shim, Ju Hyun
Lee, Han Chu
An, Jihyun
Kim, Mi-Ju
Kim, Kyu-pyo
Ahn, Sung-Min
Yu, Eunsil
LIVER CANCER, 2019, 8 (01) : 12 - 23
[45] HBx Modulates Drug Resistance of Sorafenib-Resistant Hepatocellular Carcinoma Cells
Liu, Yaping
Liu, Xu
Luo, Miaosha
Li, Yarui
Li, Hongxia
DISCOVERY MEDICINE, 2023, 35 (179) : 1035 - 1042
[46] The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma*
Augello, Giuseppa
Emma, Maria Rita
Azzolina, Antonina
Puleio, Roberto
Condorelli, Lucia
Cusimano, Antonella
Giannitrapani, Lydia
McCubrey, James A.
Iovanna, Juan Lucio
Cervello, Melchiorre
CANCER LETTERS, 2021, 519 : 250 - 262
[47] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
Li, Weidong
Dong, Xuesong
He, Changjun
Tan, Gang
Li, Ziyi
Zhai, Bo
Feng, Jing
Jiang, Xian
Liu, Chang
Jiang, Hongchi
Sun, Xueying
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
[48] First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma
Kim, Richard D.
Sarker, Debashis
Meyer, Tim
Yau, Thomas
Macarulla, Teresa
Park, Joong-Won
Choo, Su Pin
Hollebecque, Antoine
Sung, Max W.
Lim, Ho-Yeong
Mazzaferro, Vincenzo
Trojan, Joerg
Zhu, Andrew X.
Yoon, Jung-Hwan
Sharma, Sunil
Lin, Zhong-Zhe
Chan, Stephen L.
Faivre, Sandrine
Feun, Lynn G.
Yen, Chia-Jui
Dufour, Jean-Francois
Palmer, Daniel H.
Llovet, Josep M.
Manoogian, Melissa
Tugnait, Meera
Stransky, Nicolas
Hagel, Margit
Kohl, Nancy E.
Lengauer, Christoph
Sherwin, Cori Ann
Schmidt-Kittler, Oleg
Hoeflich, Klaus P.
Shi, Hongliang
Wolf, Beni B.
Kang, Yoon-Koo
CANCER DISCOVERY, 2019, 9 (12) : 1696 - 1707
[49] KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP
Jin, Yan
Yang, Ruonan
Ding, Jingyi
Zhu, Fengqi
Zhu, Cunle
Xu, Qingguo
Cai, Jinzhen
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 585 : 185 - 190
[50] Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
Eun, Jung Woo
Yoon, Jung Hwan
Ahn, Hye Ri
Kim, Seokhwi
Kim, Young Bae
Lim, Su Bin
Park, Won
Kang, Tae Wook
Baek, Geum Ok
Yoon, Moon Gyeong
Son, Ju A.
Weon, Ji Hyang
Kim, Soon Sun
Cho, Hyo Jung
Cheong, Jae Youn
CANCER COMMUNICATIONS, 2023, 43 (04) : 455 - 479

← 1 2 3 4 5 →